首页 | 本学科首页   官方微博 | 高级检索  
     


Identifying Stage B colorectal cancer patients at high risk of tumor recurrence and death
Authors:Dr. Hugh E. Mulcahy M.D.   M.R.C.P.I.  Mary Toner M.D.   M.R.C.Path.  Stephen E. Patchett M.D.   M.R.C.P.I.  Leslie Daly M.Sc   Ph.D.   Hon. M.F.P.H.M.  Diarmuid P. O'Donoghue M.D.   F.R.C.P.   F.R.C.P.I.
Affiliation:(1) Gastroenterology & Liver Unit, St Vincent's Hospital and University College Dublin, Dublin, Ireland;(2) Department of Pathology, St Vincent's Hospital and University College Dublin, Dublin, Ireland;(3) Department of Public Health Medicine & Epidemiology, St Vincent's Hospital and University College Dublin, Dublin, Ireland;(4) Digestive Diseases Research Centre, St Bartholomew's Medical College, Charterhouse Square, EC1 M 6BQ London, UK
Abstract:PURPOSE: This study was designed to determine clinical and pathologic variables associated with poor outcome following resection of Stage B colorectal cancer. METHODS: This was a retrospective study of 117 patients with Stage B cancer who underwent curative surgery and survived the postoperative period. Fourteen clinical and pathologic features were studied. Clinical data were extracted from a prospective colorectal cancer database, and histologic slides were retreived and examined by a pathologist blinded as to clinical details and outcome. RESULTS: After a median follow-up period of 8.2 years, bowel obstruction was significantly related to a poor prognosis (log-rank test; P=0.03). Extensive necrosis (P=0.01) and perineural invasion (P= 0.03) were also associated with decreased survival. Vascular invasion was associated with poor long-term outcome in the subgroup of patients with rectal (P=0.07) but not colonic (P=0.57) cancer. Multivariate regression analysis identified both tumor necrosis (P=0.01) and perineural invasion (P=0.03) as independently related to outcome. CONCLUSION: Further study of prognostic indicators might result in an algorithm to distinguish Stage B cases at high risk of tumor recurrence and death. Such patients could be included in future trials of adjuvant therapies.Presented in part at the meeting of the American Gastroenterological Association, Boston, Massachusetts, May 16 to 19, 1993. Published in abstract form in Gastroenterology 1993;104:A432.
Keywords:Colorectal neoplasms  Staging  Prognosis  Adjuvant therapy
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号